These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 2429094)

  • 1. Influence of prolonged submaximal exercise on the pharmacokinetics of verapamil in humans.
    Mooy J; Arends B; van Kemenade J; Boehm R; Rahn KH; van Baak M
    J Cardiovasc Pharmacol; 1986; 8(5):940-2. PubMed ID: 2429094
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of physical exercise on the pharmacokinetics of propranolol.
    Arends BG; Böhm RO; van Kemenade JE; Rahn KH; van Baak MA
    Eur J Clin Pharmacol; 1986; 31(3):375-7. PubMed ID: 3792439
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of verapamil in man.
    Koike Y; Shimamura K; Shudo I; Saito H
    Res Commun Chem Pathol Pharmacol; 1979 Apr; 24(1):37-47. PubMed ID: 432439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of verapamil in patients with renal failure.
    Mooy J; Schols M; v Baak M; v Hooff M; Muytjens A; Rahn KH
    Eur J Clin Pharmacol; 1985; 28(4):405-10. PubMed ID: 4029246
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simultaneous determination of the intravenous and oral pharmacokinetic parameters of D,L-verapamil using stable isotope-labelled verapamil.
    Eichelbaum M; Somogyi A; von Unruh GE; Dengler HJ
    Eur J Clin Pharmacol; 1981 Jan; 19(2):133-7. PubMed ID: 7202473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of (+)-, (-)- and (+/-)-verapamil after intravenous administration.
    Eichelbaum M; Mikus G; Vogelgesang B
    Br J Clin Pharmacol; 1984 Apr; 17(4):453-8. PubMed ID: 6721991
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pharmacokinetics and pharmacodynamics of verapamil in healthy volunteers after single oral and sublingual administration].
    Woodcock BG; Wörner P; Rietbrock N; Schwabe L; Frömming KH
    Arzneimittelforschung; 1982; 32(12):1567-71. PubMed ID: 6891597
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Verapamil disposition kinetics in chronic atrial fibrillation.
    Kates RE; Keefe DL; Schwartz J; Harapat S; Kirsten EB; Harrison DC
    Clin Pharmacol Ther; 1981 Jul; 30(1):44-51. PubMed ID: 7237897
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical pharmacokinetics of verapamil in patients with atrial fibrillation.
    Anderson P; BondessoN U; Sylvén C
    Eur J Clin Pharmacol; 1982; 23(1):49-57. PubMed ID: 7128672
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The pharmacology of verapamil. IV. Kinetic and dynamic effects after single intravenous and oral doses.
    McAllister RG; Kirsten EB
    Clin Pharmacol Ther; 1982 Apr; 31(4):418-26. PubMed ID: 7060323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of cimetidine on verapamil disposition.
    Loi CM; Rollins DE; Dukes GE; Peat MA
    Clin Pharmacol Ther; 1985 Jun; 37(6):654-7. PubMed ID: 4006365
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential induction of prehepatic and hepatic metabolism of verapamil by rifampin.
    Fromm MF; Busse D; Kroemer HK; Eichelbaum M
    Hepatology; 1996 Oct; 24(4):796-801. PubMed ID: 8855178
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics, bioavailability and ECG response of verapamil in patients with liver cirrhosis.
    Somogyi A; Albrecht M; Kliems G; Schäfer K; Eichelbaum M
    Br J Clin Pharmacol; 1981 Jul; 12(1):51-60. PubMed ID: 7248141
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of oral verapamil therapy on antipyrine clearance.
    Rumiantsev DO; Piotrovskii VK; Riabokon OS; Slastnikova ID; Kokurina EV; Metelitsa VI
    Br J Clin Pharmacol; 1986 Nov; 22(5):606-9. PubMed ID: 3790408
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Physiological disposition of verapamil in man.
    Schomerus M; Spiegelhalder B; Stieren B; Eichelbaum M
    Cardiovasc Res; 1976 Sep; 10(5):605-12. PubMed ID: 971476
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravenous verapamil kinetics in rats: marked arteriovenous concentration difference and comparison with humans.
    Manitpisitkul P; Chiou WL
    Biopharm Drug Dispos; 1993 Oct; 14(7):555-66. PubMed ID: 8251610
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of calcium blockers in patients with renal insufficiency and in geriatric patients.
    Storstein L; Larsen A; Midtbø K; Saevareid L
    Acta Med Scand Suppl; 1984; 681():25-30. PubMed ID: 6587753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disposition and pharmacologic effects of R/S-verapamil in patients with chronic atrial fibrillation: an investigation comparing single and multiple dosing.
    Busse D; Fromm MF; Mörike K; Drescher S; Kühlkamp V; Eichelbaum M
    Clin Pharmacol Ther; 2001 May; 69(5):324-32. PubMed ID: 11372000
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Age-related changes in the pharmacodynamics of verapamil.
    Arnold TH; Vallner JJ; Tackett RL
    Am Heart J; 1985 Nov; 110(5):981-5. PubMed ID: 4061274
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Relationship between the pharmacokinetics of verapamil and its electrocardiographic effects].
    Koike Y
    Hokkaido Igaku Zasshi; 1983 Jan; 58(1):17-29. PubMed ID: 6840665
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.